share

40-o-[2-(T-Butyldimethylsilyl)Oxy]Ethyl Rapamycin CAS NO 159351-68-5


Unit Price:

CAS No.:159351-68-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

40-O-[2-(T-Butyldimethylsilyl)Oxy]Ethyl Rapamycin is a chemically modified derivative of the potent immunosuppressant and mTOR inhibitor, rapamycin (sirolimus). This compound is a critical advanced pharmaceutical intermediate designed for the synthesis of next-generation rapamycin analogs with tailored pharmacokinetic and pharmacodynamic properties. It is primarily utilized by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in developing novel therapeutics for oncology, immunosuppression, and anti-aging research.

Application

  • Key Intermediate for Novel Rapalogs: Serves as a pivotal building block for synthesizing ester and ether derivatives of rapamycin with enhanced solubility or targeting.
  • Preclinical Drug Discovery: Used in medicinal chemistry programs to explore structure-activity relationships (SAR) of mTOR pathway inhibitors.
  • Bioconjugation & Prodrug Development: The silyl-protected hydroxyl group allows for selective deprotection and further functionalization, enabling the creation of antibody-drug conjugates (ADCs) or prodrugs.
  • Chemical Biology Research: Employed as a tool compound to study mTOR signaling and cellular processes like autophagy and senescence.
  • Process Chemistry & Scale-Up: Supplied to CROs and CDMOs for the development and optimization of scalable synthetic routes for candidate drugs.

Basic Information

Product Name 40-O-[2-(T-Butyldimethylsilyl)Oxy]Ethyl Rapamycin
CAS No. 159351-68-5
Molecular Formula C56H91NO14Si
Molecular Weight 1034.41 g/mol
Synonyms 40-O-[2-(tert-Butyldimethylsilyl)oxyethyl]rapamycin; 40-O-(2-((tert-Butyldimethylsilyl)oxy)ethyl)sirolimus; TBDMS-O-Ethyl Rapamycin; Rapamycin, 40-O-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-; 40-O-(2-Hydroxyethyl)rapamycin 2-(tert-butyldimethylsilyl) ether; CCI-779 Intermediate (Temsirolimus precursor analog)
EINECS Contact for details

Quality Control

Our high-purity pharmaceutical intermediate is manufactured under controlled conditions and undergoes rigorous analytical characterization. Quality is assured through HPLC, NMR, and mass spectrometry to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing batch-specific results is provided with each shipment, ensuring traceability and compliance with research-grade material standards.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a freezer. This product is hygroscopic (moisture-sensitive). Allow the sealed vial to warm to room temperature before opening to minimize condensation and moisture uptake. For long-term storage, keep desiccated under an inert atmosphere.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Retention time corresponds to reference standard
Identification (NMR) Spectrum consistent with structure
Purity (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.